Open AccessPB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Author(s) -
Wei X.,
Wang L.,
Liang J.,
Shen H.,
Li J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851408.09459.79
Subject(s) - rituximab , medicine , lenalidomide , diffuse large b cell lymphoma , gemcitabine , oxaliplatin , oncology , regimen , progressive disease , lymphoma , refractory (planetary science) , surgery , gastroenterology , chemotherapy , cancer , multiple myeloma , colorectal cancer , physics , astrobiology